FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2109197125> ?p ?o ?g. }

• W2109197125 endingPage "3567" @default.
• W2109197125 startingPage "3557" @default.
• W2109197125 abstract "Abstract Purpose: Transforming growth factor-β (TGF-β)-mediated epithelial-to-mesenchymal transition (EMT) has been shown to occur in some cancers; however, the pathway remains controversial and varies with different cancers. In addition, the mechanisms by which TGF-β and the EMT contribute to prostate cancer recurrence are largely unknown. In this study, we elucidated TGF-β-mediated EMT as a predictor of disease recurrence after therapy for prostate cancer, which has not been reported before. Experimental Design: We analyzed TGF-β-induced EMT using nuclear factor-κB (NF-κB) as an intermediate mediator in prostate cancer cell lines. A total of 287 radical prostatectomy specimens were evaluated using immunohistochemistry in a high-throughput tissue microarray analysis. Levels of TGF-β signaling components and EMT-related factors were analyzed using specific antibodies. Results were expressed as the percentage of cancer cells that stained positive for a given antibody and were correlated with disease recurrence rates at a mean of 7 years following radical prostatectomy. Results: In prostate cancer cell lines, TGF-β-induced EMT was mediated by NF-κB signaling. Blockade of NF-κB or TGF-β signaling resulted in abrogation of vimentin expression and inhibition of the invasive capability of these cells. There was high risk of biochemical recurrence associated with tumors that displayed high levels of expression of TGF-β1, vimentin, and NF-κB and low level of cytokeratin 18. This was particularly true for vimentin, which is independent of patients' Gleason score. Conclusions: The detection of NF-κB-mediated TGF-β-induced EMT in primary tumors predicts disease recurrence in prostate cancer patients following radical prostatectomy. The changes in TGF-β signaling and EMT-related factors provide novel molecular markers that may predict prostate cancer outcomes following treatment." @default.
• W2109197125 created "2016-06-24" @default.
• W2109197125 creator A5006641884 @default.
• W2109197125 creator A5015189970 @default.
• W2109197125 creator A5019669673 @default.
• W2109197125 creator A5030411648 @default.
• W2109197125 creator A5039837606 @default.
• W2109197125 creator A5040459851 @default.
• W2109197125 creator A5044026355 @default.
• W2109197125 creator A5047995082 @default.
• W2109197125 creator A5052853942 @default.
• W2109197125 creator A5058251204 @default.
• W2109197125 creator A5065869555 @default.
• W2109197125 creator A5069845633 @default.
• W2109197125 creator A5070760688 @default.
• W2109197125 creator A5071194144 @default.
• W2109197125 creator A5073389579 @default.
• W2109197125 creator A5078143614 @default.
• W2109197125 creator A5080276829 @default.
• W2109197125 date "2009-05-15" @default.
• W2109197125 modified "2023-10-17" @default.
• W2109197125 title "Nuclear Factor-κB-Mediated Transforming Growth Factor-β-Induced Expression of Vimentin Is an Independent Predictor of Biochemical Recurrence after Radical Prostatectomy" @default.
• W2109197125 cites W1965734230 @default.
• W2109197125 cites W1983628734 @default.
• W2109197125 cites W1984162437 @default.
• W2109197125 cites W1989183400 @default.
• W2109197125 cites W1992484344 @default.
• W2109197125 cites W1995152614 @default.
• W2109197125 cites W1995194065 @default.
• W2109197125 cites W2002443133 @default.
• W2109197125 cites W2036008499 @default.
• W2109197125 cites W2037023229 @default.
• W2109197125 cites W2037943063 @default.
• W2109197125 cites W2047992261 @default.
• W2109197125 cites W2053422364 @default.
• W2109197125 cites W2061476658 @default.
• W2109197125 cites W2070058781 @default.
• W2109197125 cites W2076583198 @default.
• W2109197125 cites W2077462602 @default.
• W2109197125 cites W2083713591 @default.
• W2109197125 cites W2100001148 @default.
• W2109197125 cites W2104870101 @default.
• W2109197125 cites W2113989947 @default.
• W2109197125 cites W2118650242 @default.
• W2109197125 cites W2120751702 @default.
• W2109197125 cites W2140551998 @default.
• W2109197125 cites W2146119340 @default.
• W2109197125 cites W2147865927 @default.
• W2109197125 cites W2159087758 @default.
• W2109197125 cites W2486548726 @default.
• W2109197125 cites W2907395707 @default.
• W2109197125 cites W3023689102 @default.
• W2109197125 cites W4256062813 @default.
• W2109197125 doi "https://doi.org/10.1158/1078-0432.ccr-08-1656" @default.
• W2109197125 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/19447876" @default.
• W2109197125 hasPublicationYear "2009" @default.
• W2109197125 type Work @default.
• W2109197125 sameAs 2109197125 @default.
• W2109197125 citedByCount "102" @default.
• W2109197125 countsByYear W21091971252012 @default.
• W2109197125 countsByYear W21091971252013 @default.
• W2109197125 countsByYear W21091971252014 @default.
• W2109197125 countsByYear W21091971252015 @default.
• W2109197125 countsByYear W21091971252016 @default.
• W2109197125 countsByYear W21091971252017 @default.
• W2109197125 countsByYear W21091971252018 @default.
• W2109197125 countsByYear W21091971252019 @default.
• W2109197125 countsByYear W21091971252020 @default.
• W2109197125 countsByYear W21091971252021 @default.
• W2109197125 countsByYear W21091971252022 @default.
• W2109197125 countsByYear W21091971252023 @default.
• W2109197125 crossrefType "journal-article" @default.
• W2109197125 hasAuthorship W2109197125A5006641884 @default.
• W2109197125 hasAuthorship W2109197125A5015189970 @default.
• W2109197125 hasAuthorship W2109197125A5019669673 @default.
• W2109197125 hasAuthorship W2109197125A5030411648 @default.
• W2109197125 hasAuthorship W2109197125A5039837606 @default.
• W2109197125 hasAuthorship W2109197125A5040459851 @default.
• W2109197125 hasAuthorship W2109197125A5044026355 @default.
• W2109197125 hasAuthorship W2109197125A5047995082 @default.
• W2109197125 hasAuthorship W2109197125A5052853942 @default.
• W2109197125 hasAuthorship W2109197125A5058251204 @default.
• W2109197125 hasAuthorship W2109197125A5065869555 @default.
• W2109197125 hasAuthorship W2109197125A5069845633 @default.
• W2109197125 hasAuthorship W2109197125A5070760688 @default.
• W2109197125 hasAuthorship W2109197125A5071194144 @default.
• W2109197125 hasAuthorship W2109197125A5073389579 @default.
• W2109197125 hasAuthorship W2109197125A5078143614 @default.
• W2109197125 hasAuthorship W2109197125A5080276829 @default.
• W2109197125 hasBestOaLocation W21091971251 @default.
• W2109197125 hasConcept C118131993 @default.
• W2109197125 hasConcept C121608353 @default.
• W2109197125 hasConcept C126322002 @default.
• W2109197125 hasConcept C142724271 @default.
• W2109197125 hasConcept C143998085 @default.
• W2109197125 hasConcept C147447768 @default.
• W2109197125 hasConcept C193270364 @default.
• W2109197125 hasConcept C204232928 @default.

• next